-

DOX BREAKING ALERT: Rosen Law Firm Encourages Amdocs Limited Investors with Losses to Inquire About Class Action Investigation – DOX

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Amdocs Limited (NASDAQ: DOX) resulting from allegations that Amdocs may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Amdocs securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to http://www.rosenlegal.com/cases-register-2071.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: On March 31, 2021, before markets opened, Jehoshaphat Research published a short-seller report on Amdocs. In the report, Jehoshaphat alleges that: (1) Amdocs overstated its profits, evidenced by steady parent profits despite declining subsidiary profits; (2) there was a concerning pattern of reputable auditors resigning, only to be replaced by “scandal-plagued or tiny shops”; (3) Amdocs “window-dressed” its balance sheets to keep its large borrowing a secret; and (4) former employees and direct competitors corroborated the findings, including a former American Amdocs executive, who stated, “The US business was declining at a rate of [around] 7% annually...but then we would see the company [publish results that] say North America is stable.”

On this news, Amdocs’ securities dropped by $4.35, or approximately 5.5%, from closing at $79.34 on March 30, 2021 to open at $74.99 on March 31, 2021.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

The Rosen Law Firm, P.A.

NASDAQ:DOX

Release Versions

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

More News From The Rosen Law Firm, P.A.

UNCY Deadline: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between December 29, 2025 and June 29, 2026. Unicycive describes itself as a “clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases.”For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767...

Monolithic Power Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Monolithic Power Systems, Inc. – MPWR

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Monolithic Power Systems, Inc. (NASDAQ: MPWR).If you currently own shares of Monolithic Power stock, please visit the firm’s website at https://rosenlegal.com/cases/monolithic-power-systems-inc/join for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@r...

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of UP Fintech Holding Limited Investors – TIGR

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of UP Fintech Holding Limited (NASDAQ: TIGR) between April 22, 2024 and June 2, 2026, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for UP Fintech investors under the federal securities laws.To join the UP Fintech class action, go to https://rosenlegal.com/cases/up-fintech-holding-limited/join or ca...
Back to Newsroom